Hamline University Health Law Institute 2013 Highlights
1 FDA Public Hearing on Clinical Accuracy Requirements for Point of Care Blood Glucose Meters Industry Perspective: Tighter Performance Criteria for Blood.
Politics and Health Care Mark Grapentine, JD Senior Vice President, Government Relations October 31, 2007.
Speakers: Khatereh Calleja, JD Senior Vice President, Technology and Regulatory Affairs Sandra Cohen Kalter, Vice President and Chief Regulatory Counsel,
Politics and Health Care
Emerging targets in HDL modification: Relevant data from development programs Prof. John Kastelein Academic Medical Centre Amsterdam, The Netherlands.
Emerging targets in HDL modification: Relevant data from development programs
